Antithrombotic compositions.

摘要

The invention relates to the use of 1-(3 min ,4 min -dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline or 1-(3 min ,4 min -diethoxy-benzyl)-6,7-diethoxy-3,4-dihydro-isoquinoline or (3 min ,4 min -diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium theophyllin-7-acetate or its monohydrate as active ingredient for the manufacture of medicaments for use in the treatment or prevention of conditions resulting from increased thrombocyte - aggregatory activity as a consequence of decreased prostacyclin release.